Astor Scientific

10/02/2026

09/11/2026

What is this gel image about?

09/05/2026

FDA Drug Approval Update | Sept. 3–4, 2026 💊

Two notable FDA developments:

🧬 Zanvastro (zilganersen) — Ionis
First FDA-approved treatment for Alexander disease, targeting abnormal GFAP production.

🎯 Etcamah (camizestrant) — AstraZeneca
Accelerated approval for ESR1-mutated HR+/HER2− advanced breast cancer, introducing a mutation-guided treatment strategy.

A strong two-day window for rare disease and precision oncology.

PrecisionMedicine Pharma Biotech

08/31/2026

🦠 Weekly Virus & Outbreak Update

August 24–31, 2026 | WHO & CDC

This week’s key developments:

🔴 Ebola — DRC: Outbreak continues to expand, with 5,794 confirmed cases and 2,786 deaths reported by WHO.

🔴 Measles — U.S.: 2,903 confirmed cases across 47 jurisdictions, surpassing the full-year 2025 total.

🟠 Polio: International spread remains a Public Health Emergency of International Concern (PHEIC).

🟠 Mpox: Community transmission continues in Guinea-Bissau, while WHO updated its global risk assessment.

🟡 COVID-19: Activity is increasing in the U.S., although overall respiratory illness remains low.

🟡 H5N1: Continued circulation in animals; CDC reports no unusual human influenza signal.

🟢 Uganda Ebola: Outbreak officially ended after 42 days without a new confirmed case.

🔬 What to Watch

Ebola • H5N1 • Mpox • Measles

These outbreaks continue to highlight the importance of rapid diagnostics, genomic surveillance, vaccines, therapeutics and scalable public-health infrastructure.

Sources: WHO & CDC

Polio H5N1 COVID19 PublicHealth BiomedicalResearch Biotech LifeSciences AstorScientific

08/30/2026

🧬 Radiopharma Is Scaling Up

Bristol Myers Squibb is investing $173M to build a new 225,000 sq. ft. radiopharmaceutical facility in Indiana.

☢️ Focus: next-generation cancer therapies
🔬 Includes Actinium-225 (Ac-225)
🏭 100 new jobs expected
🧬 RayzeBio’s RYZ101 is in Phase 3

The future of oncology will require not only breakthrough therapies—but the manufacturing infrastructure to deliver them at scale.

Source: Fierce Pharma

Ac225 DrugDevelopment Biotechnology BMS RayzeBio AstorScientific

Astor Scientific
www.astorscientific.us